V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029950 | 20012767 | 1.71 | 64.8 | Adjuvant (A) | 2013-07-19 | 2013-07-23 | FEC + DOCETAXEL | 02 | N | 20105488 | FEC + DOCETAXEL |
| 20029951 | 20012768 | 1.63 | 143.5 | Neo-adjuvant (N) | 2017-01-27 | 2017-02-02 | FEC + DOCETAXEL | 2 | N | 20105499 | FEC + DOCETAXEL |
| 20029952 | 20072712 | null | null | Adjuvant (A) | 2017-08-29 | 2017-09-09 | FEC 100 + DOCETAXEL | N | N | 20105500 | FEC + DOCETAXEL |
| 20029953 | 20072712 | 1.68 | 64.3 | Not known (9) | 2017-05-20 | 2017-05-24 | FEC + DOCETAXEL | 02 | N | 20105500 | FEC + DOCETAXEL |
| 20029954 | 20012769 | 1.68 | 51.9 | Adjuvant (A) | 2014-11-01 | 2014-11-02 | FEC + DOCETAXEL | 02 | N | 20105512 | FEC + DOCETAXEL |
| 20029955 | 20012770 | 1.59 | 83 | Adjuvant (A) | 2015-08-31 | 2015-09-22 | FEC + DOCETAXEL | N | N | 20105513 | FEC + DOCETAXEL |
| 20029956 | 20012770 | 1.62 | 67.2 | Adjuvant (A) | 2015-12-17 | 2015-12-18 | FEC 100 + DOCETAXEL | N | N | 20105513 | FEC + DOCETAXEL |
| 20029957 | 20012771 | 1.61 | 75.9 | Adjuvant (A) | 2015-02-08 | 2015-02-08 | FEC 100 + DOCETAXEL | 02 | N | 20105523 | FEC + DOCETAXEL |
| 20029958 | 20012771 | 1.6 | 68.5 | Adjuvant (A) | 2017-06-30 | 2017-07-07 | FEC 100 + DOCETAXEL | 2 | N | 20105523 | FEC + DOCETAXEL |
| 20029959 | 20012771 | 1.54 | 63.6 | Adjuvant (A) | 2017-06-06 | 2017-06-15 | FEC + DOCETAXEL | N | N | 20105523 | FEC + DOCETAXEL |
| 20029960 | 20012772 | 1.67 | 82.8 | Adjuvant (A) | 2013-04-01 | 2013-04-15 | FEC + DOCETAXEL | N | N | 20105545 | FEC + DOCETAXEL |
| 20029961 | 20012773 | null | 92.5 | Adjuvant (A) | 2017-07-07 | 2017-07-07 | FEC 100 + DOCETAXEL | 02 | N | 20105549 | FEC + DOCETAXEL |
| 20029962 | 20012773 | 1.57 | 79.5 | Adjuvant (A) | 2014-05-25 | 2014-06-26 | FEC 100 + DOCETAXEL | N | null | 20105549 | FEC + DOCETAXEL |
| 20029963 | 20012773 | null | null | Adjuvant (A) | 2017-06-17 | 2017-07-01 | FEC + DOCETAXEL | N | N | 20105549 | FEC + DOCETAXEL |
| 20029964 | 20128110 | 1.65 | 72 | Neo-adjuvant (N) | 2014-06-04 | 2014-06-04 | FEC + DOCETAXEL | 02 | N | 20105564 | FEC + DOCETAXEL |
| 20029965 | 20012774 | 1.61 | 72.95 | Adjuvant (A) | 2017-08-09 | 2017-08-09 | FEC + DOCETAXEL | 2 | N | 20105565 | FEC + DOCETAXEL |
| 20029966 | 20012774 | null | null | Adjuvant (A) | 2017-01-05 | 2017-01-05 | FEC + DOCETAXEL | N | N | 20105565 | FEC + DOCETAXEL |
| 20029967 | 20012774 | 1.6 | 50 | Adjuvant (A) | 2016-06-16 | 2016-06-21 | FEC + DOCETAXEL | 02 | N | 20105565 | FEC + DOCETAXEL |
| 20029968 | 20012775 | 1.53 | 91.3 | null | 2015-07-12 | 2015-07-17 | FEC + DOCETAXEL | 02 | N | 20105572 | FEC + DOCETAXEL |
| 20029969 | 20012775 | 1.58 | 56.5 | Adjuvant (A) | null | 2016-05-05 | FEC 100 + DOCETAXEL | N | N | 20105572 | FEC + DOCETAXEL |
| 20029970 | 20012776 | 1.62 | 69 | Adjuvant (A) | 2016-12-21 | 2017-01-11 | FEC + DOCETAXEL | 02 | N | 20105587 | FEC + DOCETAXEL |
| 20029971 | 20012777 | 1.56 | 78.4 | Adjuvant (A) | 2015-12-14 | 2015-12-24 | FEC + DOCETAXEL | N | N | 20105590 | FEC + DOCETAXEL |
| 20029972 | 20012777 | 1.7 | 86.7 | Curative (C) | 2016-10-09 | 2016-10-10 | FEC + DOCETAXEL | 02 | N | 20105590 | FEC + DOCETAXEL |
| 20029973 | 20012777 | 1.62 | 67.2 | Neo-adjuvant (N) | 2017-07-04 | 2017-07-04 | FEC + DOCETAXEL | 02 | N | 20105590 | FEC + DOCETAXEL |
| 20029974 | 20012777 | null | 69 | Adjuvant (A) | null | 2014-04-14 | FEC 100 + DOCETAXEL | null | null | 20105590 | FEC + DOCETAXEL |
| 20029975 | 20012778 | null | 78 | Adjuvant (A) | 2018-01-27 | 2018-02-12 | FEC + DOCETAXEL | N | N | 20105611 | FEC + DOCETAXEL |
| 20029976 | 20012778 | 1.65 | null | Adjuvant (A) | 2014-10-03 | 2014-10-21 | FEC + DOCETAXEL | N | null | 20105611 | FEC + DOCETAXEL |
| 20029977 | 20012779 | null | null | Adjuvant (A) | 2015-11-28 | 2015-12-06 | FEC + DOCETAXEL | N | N | 20105616 | FEC + DOCETAXEL |
| 20029978 | 20012779 | 1.66 | 111.3 | Neo-adjuvant (N) | 2016-05-02 | 2016-05-16 | FEC 100 + DOCETAXEL | 2 | N | 20105616 | FEC + DOCETAXEL |
| 20029979 | 20012780 | null | null | null | 2017-12-03 | 2018-01-19 | FEC + DOCETAXEL | N | N | 20105618 | FEC + DOCETAXEL |
| 20029980 | 20012780 | 1.65 | 84.6 | Not known (9) | 2016-10-29 | 2016-10-29 | FEC + DOCETAXEL | N | N | 20105618 | FEC + DOCETAXEL |
| 20029981 | 20012781 | 1.62 | 58 | Neo-adjuvant (N) | 2014-09-26 | 2014-10-01 | FEC + DOCETAXEL | 02 | N | 20105626 | FEC + DOCETAXEL |
| 20029982 | 20012782 | 1.71 | 86.2 | Neo-adjuvant (N) | 2013-10-27 | 2013-10-28 | FEC + DOCETAXEL | 2 | Y | 20105627 | FEC + DOCETAXEL |
| 20029983 | 20012782 | 1.5 | 88.8 | Adjuvant (A) | 2015-08-19 | 2015-08-28 | FEC + DOCETAXEL | N | N | 20105627 | FEC + DOCETAXEL |
| 20029984 | 20012783 | 1.6 | 58.8 | Not known (9) | null | 2016-07-01 | FEC + DOCETAXEL | N | N | 20105635 | FEC + DOCETAXEL |
| 20029985 | 20012783 | 1.62 | 62.1 | Adjuvant (A) | 2017-02-21 | 2017-02-26 | FEC 100 + DOCETAXEL | 99 | null | 20105635 | FEC + DOCETAXEL |
| 20029986 | 20012784 | null | 66.8 | Adjuvant (A) | 2013-09-07 | 2013-09-25 | FEC 100 + DOCETAXEL | N | N | 20105639 | FEC + DOCETAXEL |
| 20029987 | 20012784 | 1.6 | 60 | Adjuvant (A) | 2018-04-16 | 2018-04-16 | FEC + DOCETAXEL | 02 | null | 20105639 | FEC + DOCETAXEL |
| 20029988 | 20012785 | 1.58 | 61.6 | Not known (9) | 2014-05-27 | 2014-05-27 | FEC + DOCETAXEL | 02 | N | 20105644 | FEC + DOCETAXEL |
| 20029989 | 20012785 | 1.67 | 120.8 | null | 2018-03-19 | 2018-03-19 | FEC + DOCETAXEL | 02 | N | 20105644 | FEC + DOCETAXEL |
| 20029990 | 20012785 | 1.52 | 64 | Neo-adjuvant (N) | 2014-12-01 | 2014-12-09 | FEC 100 + DOCETAXEL | 2 | N | 20105644 | FEC + DOCETAXEL |
| 20029991 | 20012785 | 1.75 | 66.3 | null | 2013-09-29 | 2013-10-10 | FEC + DOCETAXEL | 2 | N | 20105644 | FEC + DOCETAXEL |
| 20029992 | 20012785 | 1.73 | 104 | Adjuvant (A) | null | 2016-01-11 | FEC + DOCETAXEL | N | N | 20105644 | FEC + DOCETAXEL |
| 20029993 | 20143155 | 1.62 | 87 | Palliative (P) | 2016-02-17 | 2016-02-23 | FEC + DOCETAXEL | 02 | N | 20105656 | FEC + DOCETAXEL |
| 20029994 | 20143155 | 1.75 | 65 | Adjuvant (A) | 2016-04-08 | 2016-04-27 | FEC + DOCETAXEL | 2 | N | 20105656 | FEC + DOCETAXEL |
| 20029995 | 20147355 | 1.59 | 73.6 | Adjuvant (A) | 2016-09-06 | 2016-09-13 | FEC + DOCETAXEL | 02 | null | 20105663 | FEC + DOCETAXEL |
| 20029996 | 20147355 | 1.63 | 59.8 | Neo-adjuvant (N) | null | 2015-11-11 | FEC + DOCETAXEL | N | N | 20105663 | FEC + DOCETAXEL |
| 20029997 | 20012786 | 1.43 | 62 | Neo-adjuvant (N) | 2015-12-25 | 2016-01-11 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20105667 | FEC + DOCETAXEL |
| 20029998 | 20012787 | 1.54 | 71.8 | Adjuvant (A) | null | 2015-06-03 | FEC 100 + DOCETAXEL | N | N | 20105669 | FEC + DOCETAXEL |
| 20029999 | 20012788 | null | null | Neo-adjuvant (N) | 2013-09-08 | 2013-09-10 | FEC 100 + DOCETAXEL | N | null | 20105673 | FEC + DOCETAXEL |